Group 1 - The company provides comprehensive solutions for the medical diagnostics industry, offering third-party medical testing and pathology diagnosis services, as well as well-known in vitro diagnostic products and research technical services [3] - The company has developed a systematic, large-scale, and networked service system, which includes five core centers: medical testing center, pathology diagnosis center, precision testing center, academic exchange center, and public health testing center [3] - The company aims to enhance the standardization of grassroots medical laboratories and the professional construction of precision laboratories, integrating high-end medical resources to achieve mutual recognition of medical testing results and collaborative sharing of pathology diagnosis resources [3] Group 2 - The company has changed its accounting firm to Rongcheng Accounting Firm (Special General Partnership) for the current reporting period [1] - The board of directors approved a profit distribution plan, proposing a cash dividend of 2 yuan (including tax) for every 10 shares, with no bonus shares distributed [2] - There are no preferred shareholders or significant changes in the top 10 shareholders during the reporting period [4]
上海兰卫医学检验所股份有限公司2024年年度报告摘要